Forsta AP Fonden Grows Position in Kenvue Inc. (NYSE:KVUE)

Forsta AP Fonden raised its position in Kenvue Inc. (NYSE:KVUE) by 9.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 416,775 shares of the company’s stock after acquiring an additional 34,400 shares during the quarter. Forsta AP Fonden’s holdings in Kenvue were worth $9,640,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Kenvue by 143.0% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 293,310 shares of the company’s stock valued at $6,822,000 after purchasing an additional 172,596 shares in the last quarter. Osborne Partners Capital Management LLC purchased a new position in Kenvue in the third quarter valued at $1,036,000. Allworth Financial LP increased its holdings in Kenvue by 5.9% in the third quarter. Allworth Financial LP now owns 20,023 shares of the company’s stock valued at $463,000 after buying an additional 1,113 shares during the last quarter. Cromwell Holdings LLC raised its stake in Kenvue by 190.6% in the third quarter. Cromwell Holdings LLC now owns 6,341 shares of the company’s stock valued at $147,000 after buying an additional 4,159 shares in the last quarter. Finally, Country Club Bank lifted its holdings in Kenvue by 74.1% during the 3rd quarter. Country Club Bank now owns 245,419 shares of the company’s stock worth $5,708,000 after buying an additional 104,425 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of a number of recent analyst reports. Bank of America increased their price objective on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. Jefferies Financial Group initiated coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective on the stock. UBS Group boosted their price objective on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 target price on the stock. in a research report on Tuesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and an average target price of $22.64.

Kenvue Stock Performance

NYSE KVUE opened at $22.64 on Monday. The firm has a market cap of $43.35 billion, a P/E ratio of 29.03, a P/E/G ratio of 3.00 and a beta of 1.40. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $23.55. The business’s 50-day moving average price is $22.41 and its 200 day moving average price is $20.29. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company had revenue of $4 billion for the quarter, compared to the consensus estimate of $3.93 billion. During the same period last year, the business posted $0.32 EPS. The company’s revenue was down .3% on a year-over-year basis. On average, equities research analysts expect that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be paid a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.62%. Kenvue’s dividend payout ratio is currently 105.13%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.